日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Stress in dermatology patients: A multicenter observational study of 8295 outpatients and controls from 22 European clinics

皮肤科患者的压力:一项来自22家欧洲诊所的8295名门诊患者和对照组的多中心观察性研究

Balieva, Flora; Schut, Christina; Szabó, Csanád; Sampogna, Francesca; Dalgard, Florence J; Altunay, Ilknur K; Bewley, Anthony; Ferreira, Bárbara Roque; Finlay, Andrew Y; Gieler, Uwe; Gracia-Cazaña, Tamara; Grivcheva-Panovska, Vesna; Jemec, Gregor B; Legat, Franz J; Lien, Lars; Lvov, Andrey; Marron, Servando E; Misery, Laurent; Reich, Adam; Romanov, Dmitry; Koulil, Saskia Spillekom-van; Ständer, Sonja; Svensson, Ake; Szepietowski, Jacek C; Thompson, Andrew R; Titeca, Geraldine; Tomás-Aragonés, Lucía; Vulink, Nienke; Zeidler, Claudia; Kupfer, Jörg

Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial

Nemolizumab治疗中重度结节性痒疹患者的疗效和安全性:OLYMPIA 1随机临床3期试验

Ständer, Sonja; Yosipovitch, Gil; Legat, Franz J; Reich, Adam; Paul, Carle; Simon, Dagmar; Naldi, Luigi; Metz, Martin; Tsianakas, Athanasios; Pink, Andrew; Fage, Simon; Micali, Giuseppe; Weisshaar, Elke; Sundaram, Hema; Metelitsa, Andrei; Augustin, Matthias; Wollenberg, Andreas; Homey, Bernhard; Fargnoli, Maria Concetta; Sofen, Howard; Korman, Neil J; Skov, Lone; Chen, Xiaoxiao; Jabbar-Lopez, Zarif K; Piketty, Christophe; Kwatra, Shawn G

Optimal Itch Response in Adults Treated with Dupilumab for Moderate-to-Severe Atopic Dermatitis

使用度普利尤单抗治疗中重度特应性皮炎的成人患者可获得最佳止痒效果

Ständer, Sonja; Yosipovitch, Gil; Kim, Brian S; Steinhoff, Martin; Armstrong, April; Legat, Franz J; Kabashima, Kenji; Nakahara, Takeshi; Igarashi, Atsuyuki; Praestgaard, Amy H; Nguyen, Tien V; Bastian, Mike

Crusted Scabies in a Patient being Treated with Spesolimab for Generalized Pustular Psoriasis

接受 Spesolimab 治疗泛发性脓疱型银屑病的患者出现结痂性疥疮

Schratter, Hanna; Graier, Thomas; Legat, Franz; Hofmann-Wellenhof, Rainer; Wolf, Peter

Lebrikizumab Improved Itch Symptoms and Reduced Itch Interference on Sleep over 52 Weeks in Patients with Moderate-to-Severe Atopic Dermatitis in Two Phase 3 Trials

两项3期临床试验表明,在为期52周的治疗中,Lebrikizumab改善了中重度特应性皮炎患者的瘙痒症状,并减少了瘙痒对睡眠的干扰。

Yosipovitch, Gil; Lio, Peter A; Rosmarin, David; Legat, Franz J; Serra-Baldrich, Esther; Carrascosa, Jose-Manuel; Bardolet, Laia; Crane, Heidi; Casillas, Marta; Pierce, Evangeline; Zhong, Jinglin; ElMaraghy, Hany; Ständer, Sonja

European, multicentre, prospective observational phase IV clinical study to assess the impact of lebrikizumab on health-related well-being and control of skin manifestations in patients with moderate-to-severe atopic dermatitis (ADTrust): study protocol

一项欧洲多中心前瞻性观察性IV期临床研究,旨在评估lebrikizumab对中重度特应性皮炎患者健康相关福祉和皮肤表现控制的影响(ADTrust):研究方案

Augustin, Matthias; Bewley, Anthony; Brüggen, Marie-Charlotte; de Bruin-Weller, Marjolein S; Ezzedine, Khaled; Ferrucci, Silvia M; Gkalpakiotis, Spyridon; Herranz, Pedro; Johansson, Emma K; Kampe, Tomáš; Lapeere, Hilde; Legat, Franz J; Rehbinder, Eva Maria; Szepietowski, Jacek C; Torres, Tiago; Vestergaard, Christian; Werfel, Thomas; Domenech, Arnau; Massana, Eric; Koscielny, Volker; Narayanan, Siva; Kasujee, Ismail; Gutermuth, Jan

Predictors of treatment survival in patients with plaque psoriasis treated with phototherapy: registry analysis

光疗治疗斑块状银屑病患者生存率的预测因素:注册研究分析

Graier, Thomas; Bordag, Natalie; Hofer, Angelika; Gruber-Wackernagel, Alexandra; Legat, Franz; Widnig, Alice; Falkensteiner, Katharina; Weger, Wolfgang; Salmhofer, Wolfgang; Wolf, Peter

Metabolomic and Lipidomic Alterations in Patients with Atopic Dermatitis with Dupilumab-Associated Ocular Surface Disease.

伴有度普利尤单抗相关眼表疾病的特应性皮炎患者的代谢组学和脂质组学改变

Patra VijayKumar, Woltsche Nora, Bordag Natalie, Cerpes Urban, Bokanovic Danijela, Repelnig Maria, Clement Yohann, Perchthaler Isabella, Köfeler Harald, Fischl Manuela, Legat Franz, Wedrich Andreas, Horwath-Winter Jutta, Ayciriex Sophie, Wolf Peter

Stable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 Weeks

使用Lebrikizumab治疗特应性皮炎患者52周后,瘙痒和睡眠症状稳定改善。

Yosipovitch, Gil; Lio, Peter; Legat, Franz J; Chovatiya, Raj; Deleuran, Mette; Pierce, Evangeline; Casillas, Marta; Ding, Yuxin; Yang, Fan E; Bardolet, Laia; Ständer, Sonja

Narrowband-ultraviolet B vs Broadband-ultraviolet B in Treatment of Chronic Pruritus: A Randomized, Single-blinded, Non-inferiority Study

窄谱紫外线B与宽谱紫外线B治疗慢性瘙痒的疗效比较:一项随机、单盲、非劣效性研究

Kupsa, Romana; Gruber-Wackernagel, Alexandra; Hofer, Angelika; Quehenberger, Franz; Wolf, Peter; Legat, Franz J